Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI · NASDAQ Global Select
-$0.15 today
Vol 2.73M · Avg 2.42M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+146.45%
Period High
$5.22
Period Low
$2.03
Latest
$5.20
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Tyra Biosciences, Inc.
NASDAQ:TYRA
$1.67B
Septerna, Inc.
NASDAQ:SEPN
$1.57B
Vir Biotechnology, Inc.
NASDAQ:VIR
$1.52B
Iovance Biotherapeutics, Inc.
NASDAQ:IOVA
$1.39B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.25B
Kura Oncology, Inc.
NASDAQ:KURA
$853.25M
Replimune Group, Inc.
NASDAQ:REPL
$835.63M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$581.39M
Prime Medicine, Inc.
NASDAQ:PRME
$562.62M
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$189.18M
What is the latest MRVI filing?
The latest filing shown is 4 dated Jun 10, 2026.
How many recent filings does MRVI have?
Intrinsic Alpha currently shows 20 recent filings for MRVI.
Explore More
Continue the stock analysis
Jump to another research area for this company.